Interactions Between Diet, Microbiome and Abiotic Conditions in the Gut
PRIMA
Towards Personalized Dietary Recommendations Based on the Interaction Between Diet, Microbiome and Abiotic Conditions in the Gut
1 other identifier
observational
63
1 country
1
Brief Summary
The aim of this study is to explore the interplay between environmental (abiotic) factors in the gut and the gut microbiota composition, diversity and metabolism. Such insights could help us understand personal responses to diets and be a first step towards personalized dietary recommendations targeting the gut microbiome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 18, 2021
CompletedStudy Start
First participant enrolled
April 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2021
CompletedDecember 6, 2024
December 1, 2024
8 months
March 4, 2021
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Faecal pH vs gut microbial saccharolytic/proteolytic metabolism
We test whether faecal pH is positively associated with microbial-derived proteolytic metabolites (i.e. p-cresol sulfate and phenylacetylglutamine) in urine and negatively associated with microbial-derived saccharolytic metabolites in faeces (i.e. acetate, butyrate and propionate)
Day 1-9
Secondary Outcomes (6)
Abiotic factors vs faecal metagenomic profile
Day 1-9
Abiotic factors vs faecal metabolome
Day 1-9
Abiotic factors vs urine metabolome
Day 1-9
Abiotic factors vs blood metabolome
Day 2 and 9
Abiotic factors vs microbial-derived metabolites
Day 1-9
- +1 more secondary outcomes
Other Outcomes (34)
Faecal microbiome
Day 1-9
Faecal metabolome
Day 1-9
In vitro metabolic profiling
Day 1-9
- +31 more other outcomes
Interventions
9-days study with habitual diet including one standardized breakfast on a single day
Eligibility Criteria
Healthy volunteers
You may qualify if:
- kg/m2 BMI
- Willing to daily collect a urine and stool sample at home and able to store them in their own freezer in a provided containers throughout the 9-days trial
- Willing to eat sweet corn and report corn-intestinal transit time questionnaire
- Willing to record 9 days dietary intake and defecation pattern
- Willing to have blood samples drawn two times
- Owns a device with access to the internet and is willing to use myfood24 platform
- Known ability to tolerate paracetamol and willing to consume ½ paracetamol tablet dissolved in water (250mg)
- Willing to eat rye bread, butter, jam, egg, yoghurt, berries and nuts
You may not qualify if:
- Any condition that makes the project responsible researcher to doubt the feasibility of the volunteer´s participation
- Pregnant or lactating women
- Suffering from inflammatory bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO) or inflammatory bowel diseases (IBD)
- Intake of antibiotics, diarrhea inhibitors and laxatives ˂ 1month
- Current chronic or infectious diseases
- Diagnosis of diabetes
- History of cancer within the past 5 years (except adequately-treated localized basal cell skin cancer or in situ uterine cervical cancer)
- Frequent intake of painkillers or other medication (mild antidepressants and contraceptive pills are allowed)
- Concurrent participation in another trial
- Intake of medications potentially altering gastric pH (proton pump inhibitors, histamine receptor antagonists, antacids)
- Intake of medications potentially altering the gastrointestinal motility (prokinetics, antiemetic agents, anticholinergic agents, narcotic analgetics, nonsteroidal anti-inflammatory drugs)
- Dysphagia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Copenhagenlead
- Technical University of Denmarkcollaborator
- KU Leuvencollaborator
- University of Minnesotacollaborator
Study Sites (1)
University of Copenhagen, Department of Nutrition, Exercise and Sports
Copenhagen, 1958, Denmark
Related Publications (1)
Prochazkova N, Laursen MF, La Barbera G, Tsekitsidi E, Jorgensen MS, Rasmussen MA, Raes J, Licht TR, Dragsted LO, Roager HM. Gut physiology and environment explain variations in human gut microbiome composition and metabolism. Nat Microbiol. 2024 Dec;9(12):3210-3225. doi: 10.1038/s41564-024-01856-x. Epub 2024 Nov 27.
PMID: 39604623RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 4, 2021
First Posted
March 18, 2021
Study Start
April 13, 2021
Primary Completion
November 29, 2021
Study Completion
November 29, 2021
Last Updated
December 6, 2024
Record last verified: 2024-12